We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-4.07%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$8.61B
AUM Growth
-$1.09B
Cap. Flow
-$352M
Cap. Flow %
-4.08%
Top 10 Hldgs %
30.78%
Holding
207
New
16
Increased
51
Reduced
80
Closed
30

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$58.4M
2
BSX icon
Boston Scientific
BSX
+$41.2M
3
PACB icon
Pacific Biosciences
PACB
+$38.3M
4
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$37.2M
5
CDNA icon
CareDx
CDNA
+$32.9M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$109M
2
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
+$75.3M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$73.9M
4
DHR icon
Danaher
DHR
+$66.3M
5
HUM icon
Humana
HUM
+$65.4M

Sector Composition

Rank Sector Weight
1 Healthcare 98.39%
2 Industrials 0.69%
3 Energy 0.03%
4 Technology 0.01%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
26
Danaher
DHR
$135B
$105M 1.22%
402,766
-264,784
-40% -$66.3M
INSP icon
27
Inspire Medical Systems
INSP
$1.45B
$102M 1.18%
397,506
-23,274
-6% -$5.32M
SAGE
28
DELISTED
Sage Therapeutics
SAGE
$101M 1.17%
3,052,404
-175,600
-5% -$6.6M
MOH icon
29
Molina Healthcare
MOH
$10.2B
$101M 1.17%
302,797
-11,785
-4% -$3.63M
AMED
30
DELISTED
Amedisys
AMED
$99.3M 1.15%
576,131
+86,119
+18% +$12.9M
OPCH icon
31
Option Care Health
OPCH
$3.38B
$92.3M 1.07%
3,232,787
+308,744
+11% +$7.75M
OM icon
32
Outset Medical
OM
$76.6M
$91.6M 1.06%
134,477
+97,103
+260% +$58.4M
SRPT icon
33
Sarepta Therapeutics
SRPT
$1.67B
$89.9M 1.04%
1,151,159
+324,418
+39% +$24.8M
CDNA icon
34
CareDx
CDNA
$1.93B
$85.5M 0.99%
2,311,176
+844,624
+58% +$32.9M
RVMD icon
35
Revolution Medicines
RVMD
$40.3B
$84.5M 0.98%
3,310,662
-159,500
-5% -$3.47M
EVH icon
36
Evolent Health
EVH
$483M
$84.4M 0.98%
2,612,263
+2,970
+0.1% +$77.8K
INSM icon
37
Insmed
INSM
$23.1B
$83.5M 0.97%
3,551,776
+30,915
+0.9% +$718K
SWAV
38
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$82.6M 0.96%
398,577
-28,033
-7% -$4.62M
MYOV
39
DELISTED
Myovant Sciences Ltd.
MYOV
$78M 0.91%
5,859,039
-310,000
-5% -$4.16M
KZR
40
DELISTED
Kezar Life Sciences
KZR
$77.6M 0.9%
466,815
-25,000
-5% -$3.59M
HCA icon
41
HCA Healthcare
HCA
$84.6B
$75.2M 0.87%
300,197
+5,763
+2% +$1.45M
RDUS
42
DELISTED
Radius Health, Inc.
RDUS
$73.5M 0.85%
8,318,714
+550,000
+7% +$4.17M
MDT icon
43
Medtronic
MDT
$106B
$72.8M 0.85%
656,030
-11,378
-2% -$1.2M
MGNX icon
44
MacroGenics
MGNX
$239M
$64.5M 0.75%
7,325,514
-1,234,948
-14% -$13.6M
IDXX icon
45
Idexx Laboratories
IDXX
$42.8B
$64.4M 0.75%
117,810
-169
-0.1% -$88.9K
HUM icon
46
Humana
HUM
$47B
$64.2M 0.75%
147,442
-156,255
-51% -$65.4M
REGN icon
47
Regeneron Pharmaceuticals
REGN
$69.8B
$63.1M 0.73%
90,280
-2,780
-3% -$1.76M
CI icon
48
Cigna
CI
$76.2B
$62.1M 0.72%
259,146
+13,972
+6% +$3.27M
EXEL icon
49
Exelixis
EXEL
$14B
$61.6M 0.72%
2,719,000
-140,000
-5% -$2.73M
ALGN icon
50
Align Technology
ALGN
$12.1B
$61.6M 0.72%
141,351
-5,213
-4% -$2.54M
1
2
3 4 5

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Bellevue Group's Q1 2022 Portfolio in Review

As of Q1 2022, Bellevue Group held 207 positions worth $8.61B, down 11% from $9.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellevue Group withdrew a net $352M in Q1 2022, closing 30 positions and reducing 80 holdings. Its most notable exit was VOCERA COMMUNICATIONS, INC., an estimated $75.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 98% a quarter earlier, followed by Industrials and Energy.

Against the trend, Bellevue Group opened a new position in Aurinia Pharmaceuticals worth $29.8M.

  • Bellevue Group's largest Q1 2022 buy was Aurinia Pharmaceuticals: 2,405,825 shares worth $29.8M.
  • Bellevue Group added most to Outset Medical in Q1 2022, an estimated $58.4M increase.
  • Bellevue Group's biggest Q1 2022 reduction was Biogen, cutting an estimated $109M.
  • Bellevue Group fully exited VOCERA COMMUNICATIONS, INC. in Q1 2022, selling an estimated $75.3M.
  • Bellevue Group's ten largest holdings make up 31% of its $8.61B portfolio in Q1 2022.
  • Bellevue Group opened 16 new positions and closed 30 in Q1 2022.
  • Bellevue Group's portfolio value fell 11% quarter-over-quarter to $8.61B.

Based on Bellevue Group's 13F filing for Q1 2022, filed 13 May 2022.